Accès ouvert
2026
preprint
OpenAlex
Ramon Farre, Raffaella Salama, Miguel Angel Rodriguez-Lazaro, Kasra Kiarostami et autres
ABSTRACT Background The COVID-19 pandemic exposed critical shortages of mechanical ventilators, particularly in low-resource settings. Disruptions in global supply chains and dependence on specialized components highlighted the need for scalable, locally manufacturing alternatives for emergency respiratory support. Aim To describe and evaluate …
es, ie, fr, us
(code pays fourni par la source)
Accès ouvert
2026
review
OpenAlex
Andrés Barba, Sergio Martínez-Recio, Mikel Portu, Ana Maria Soto-Cambres et autres
BACKGROUND AND OBJECTIVE: Small cell lung cancer (SCLC) is an aggressive neuroendocrine malignancy with frequent relapse and poor long-term survival. We review current and emerging therapeutic strategies across disease stages, emphasizing multimodal treatment and novel systemic agents. METHODS: We performed a narrative …
es
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
Davide Dalfovo, Carolina Sassorossi, E. De Paolis, Annalisa Campanella et autres
Non-small cell lung cancer (NSCLC) remains the leading cause of cancer-related mortality globally. While multi-modal artificial intelligence (AI) models offer significant predictive potential, their translation into routine clinical practice is delayed by the “black box” nature of complex algorithms and the fragmentation …
de, it, ca, jp, hu, es, tr
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
E. De Paolis, J. Evangelista, Davide Dalfovo, Carolina Sassorossi et autres
Lung cancer (LC) is a leading cause of cancer-related mortality. Precision medicine has reshaped disease treatment through molecularly guided therapies, with limited implementation in early stage LC. We report preliminary results from the LANTERN project, providing an overview of the mutational landscape …
it, de, es, tr
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
J. Evangelista, E. De Paolis, Davide Dalfovo, Carolina Sassorossi et autres
Biomarker testing is essential for identifying lung cancer (LC) patients with actionable oncogenic drivers. In this perspective, early stage settings remain less explored. Co-occurring mutations involving established drivers (eg, EGFR) may modulate responses to targeted therapies. This study aimed to define the …
it, de, es, tr
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
C. Sassorossi, Alessandra Cancellieri, Davide Dalfovo, I. Carriero et autres
it, de, hu, es, tr
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
C. Sassorossi, E. De Paolis, J. Evangelista, Davide Dalfovo et autres
it, de, hu, es, tr
(code pays fourni par la source)
Accès ouvert
2026
preprint
OpenAlex
Filippo Lococo, Carolina Sassorossi, Davide Dalfovo, Annalisa Campanella et autres
it, jp, de, ca, my, hu, es, tr
(code pays fourni par la source)
2026
article
OpenAlex
Sandra Valdivielso Moré, Núria Farré, Neus Badosa, Nuria Rodríguez de Francisco et autres
es, ie
(code pays fourni par la source)
2026
article
OpenAlex
Sandra Valdivielso Moré, Núria Farré, Neus Badosa, Nuria Rodríguez de Francisco et autres
es, ie
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Alicia Lozano-Borbalas, Olivia Jordi-Ollero, J. Marruecos, Núria Farré et autres
Introduction Oral mucositis (OM) is the most common acute treatment-limiting adverse effect in patients with head and neck cancer (HNC), particularly following concomitant radiotherapy (RT) and systemic therapy. However, the effects of clinical and dosimetric parameters on the onset of severe OM …
es
(code pays fourni par la source)
2025
article
OpenAlex
Filippo Lococo, Carolina Sassorossi, Annalisa Campanella, L. Boldrini et autres
it, ca, my, de, hu, es, tr
(code pays fourni par la source)